VICTHOM ANNOUNCES RESULTS OF THE ANNUAL GENERAL MEETING OF SHAREHOLDERS
June 21 2011 - 4:47PM
PR Newswire (Canada)
QUEBEC, June 21, 2011 /CNW/ -- QUEBEC, June 21, 2011 /CNW Telbec/ -
Victhom Human Bionics Inc. ("Victhom") (TSXV: VHB) today
reported the results of its Annual General Meeting of shareholders
held in Montreal, Quebec. The shareholders approved the motions put
forth at the meeting to re-appoint the four directors of the
Company: Messrs Daniel Johnson, Nitin Kaushal, Martin Leblanc and
Normand Rivard and to appoint Ernst & Young LLP as the
Company's auditors. At their meeting held directly following the
Annual General Meeting, the directors re-appointed Mr. Daniel
Johnson as Chairman of the Board. About Victhom Victhom is a
company which owns patents in the field of orthotics and
prosthetics ("O&P), including intellectual property used in the
Power Knee, the world's first and only motor-powered prosthesis for
above-knee amputees, a product distributed under license agreement
by Ossur, a global leader in the O&P market. The Company also
has a royalty agreement related to the Neurostep(®) System and
neuromodulation products in other indications (sleep apnea and
epilepsy) using the Neurobionix technology platform currently under
development by Neurostream Technologies, a General Partnership now
owned by Otto Bock, a global leader in the O&P market.
FORWARD-LOOKING STATEMENTS Some of the statements made herein may
constitute forward-looking statements. These statements relate to
future events or our future financial performance and involve known
and unknown risks, uncertainties and other factors that may cause
Victhom's actual results, performance or achievements to be
materially different from those expressed or implied by any of
Victhom's statements. Actual events or results may differ
materially. We disclaim any intention, and assume no obligation, to
update these forward-looking statements. To view this news release
in HTML formatting, please use the following URL:
http://www.cnw.ca/en/releases/archive/June2011/21/c8163.html table
valign="top" border="0" tr td valign="top" align="left"
bSource:/b /td td Victhom Human Bionics Inc. /td /tr tr td
valign="top" align="left" bFor more information:/b br/ br/ br/
/td td Normand Rivardbr/ President & CEObr/ Victhom Human
Bionics Inc.br/ Tel.: 418-872-5665 ext 107br/ Fax:
418-864-7034br/ ia cr="true"
href="mailto:normand.rivard@victhom.com"normand.rivard@victhom.com/a/i
/td /tr tr td valign="top" align="left" /td td ia cr="true"
href="http://www.victhom.com/"www.victhom.com/a/i /td /tr /table p
/p
Copyright
Victhom Human Bionics Inc. (TSXV:VHB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Victhom Human Bionics Inc. (TSXV:VHB)
Historical Stock Chart
From Jul 2023 to Jul 2024